1. Home
  2. RVMDW vs ALVOW Comparison

RVMDW vs ALVOW Comparison

Compare RVMDW & ALVOW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RVMDW
  • ALVOW
  • Stock Information
  • Founded
  • RVMDW 2014
  • ALVOW 2013
  • Country
  • RVMDW United States
  • ALVOW Luxembourg
  • Employees
  • RVMDW N/A
  • ALVOW N/A
  • Industry
  • RVMDW
  • ALVOW Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • RVMDW
  • ALVOW Health Care
  • Exchange
  • RVMDW Nasdaq
  • ALVOW Nasdaq
  • Market Cap
  • RVMDW N/A
  • ALVOW N/A
  • IPO Year
  • RVMDW N/A
  • ALVOW N/A
  • Fundamental
  • Price
  • RVMDW $0.10
  • ALVOW $2.45
  • Analyst Decision
  • RVMDW
  • ALVOW
  • Analyst Count
  • RVMDW 0
  • ALVOW 0
  • Target Price
  • RVMDW N/A
  • ALVOW N/A
  • AVG Volume (30 Days)
  • RVMDW 15.6K
  • ALVOW 15.0K
  • Earning Date
  • RVMDW 02-26-2025
  • ALVOW 02-27-2025
  • Dividend Yield
  • RVMDW N/A
  • ALVOW N/A
  • EPS Growth
  • RVMDW N/A
  • ALVOW N/A
  • EPS
  • RVMDW N/A
  • ALVOW N/A
  • Revenue
  • RVMDW $742,000.00
  • ALVOW $393,919,000.00
  • Revenue This Year
  • RVMDW N/A
  • ALVOW N/A
  • Revenue Next Year
  • RVMDW N/A
  • ALVOW N/A
  • P/E Ratio
  • RVMDW N/A
  • ALVOW N/A
  • Revenue Growth
  • RVMDW N/A
  • ALVOW 517.92
  • 52 Week Low
  • RVMDW $0.10
  • ALVOW $2.33
  • 52 Week High
  • RVMDW $0.12
  • ALVOW $2.33
  • Technical
  • Relative Strength Index (RSI)
  • RVMDW N/A
  • ALVOW N/A
  • Support Level
  • RVMDW N/A
  • ALVOW N/A
  • Resistance Level
  • RVMDW N/A
  • ALVOW N/A
  • Average True Range (ATR)
  • RVMDW 0.00
  • ALVOW 0.00
  • MACD
  • RVMDW 0.00
  • ALVOW 0.00
  • Stochastic Oscillator
  • RVMDW 0.00
  • ALVOW 0.00

About RVMDW Revolution Medicines Inc. Warrant

Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio, and SOS1 and 4EBP1/mTORC1 programs.

About ALVOW Alvotech Warrant

Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to proven treatments for various diseases.

Share on Social Networks: